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Recently, the number of human Q fever cases in the 
Netherlands increased dramatically. In response to this 
increase, dairy goats and dairy sheep were vaccinated 
against Coxiella burnetii. All pregnant dairy goats and dairy 
sheep in herds positive for Q fever were culled. We identifi ed 
the effect of vaccination on bacterial shedding by small 
ruminants. On the day of culling, samples of uterine fl uid, 
vaginal mucus, and milk were obtained from 957 pregnant 
animals in 13 herds. Prevalence and bacterial load were 
reduced in vaccinated animals compared with unvaccinated 
animals. These effects were most pronounced in animals 
during their fi rst pregnancy. Results indicate that vaccination 
may reduce bacterial load in the environment and human 
exposure to C. burnetii.
Q fever, which is caused by Coxiella burnetii, is a worldwide zoonotic infectious disease, and ruminants 
are the main reservoir for human infections (1–3). 
Ruminant infections may occasionally result in abortions, 
which are associated with shedding of large amounts of 
bacteria in placentas and birth fl uids (4). Human infections 
have been reported mainly in persons handling infected 
animals and their products (5–8). However, this disease 
has not been perceived as a major public health risk for 
the general population. In 2007, a major epidemic occurred 
in the general population in the Netherlands (9), which 
resulted in >2,300 reported cases in 2009. An explanation 
for the emergence of human Q fever was abortion clusters 
in goat herds beginning in 2005 within an intensifi ed dairy 
goat production system (10–15). This hypothesis was 
substantiated by epidemiologic studies, which indicated a 
possible spatial link between dairy goat farms and human 
cases (16).
Reduction of the number of human cases was considered 
essential by public health authorities in the Netherlands. 
One of the intervention measures taken was vaccination of 
dairy goats against C. burnetii (17). This measure assumed 
that vaccination would reduce abortions and bacterial 
shedding to levels that would reduce the number of human 
cases in the following year. Vaccination began in 2008 and 
intensifi ed in 2009. As the number of cases of C. burnetii 
infection in patients doubled in 2009, policymakers applied 
a precautionary principle and decided to cull all pregnant 
dairy goats or sheep on infected farms before the 2010 
kidding season. This measure was implemented at the 
end of 2009 and thereby precluded any fi eld analysis of 
vaccine effi cacy in the spring of 2010. However, there was 
an opportunity to sample animals shortly after they were 
humanely killed. The purpose of this study was to quantify 
the effect of vaccination on bacterial load in excreta of 
pregnant animals.
Materials and Methods
Q Fever in the Netherlands since 2005
Human Q fever cases in the Netherlands increased 
from 168 in 2007 to 1,000 in 2008 and 2,355 in 2009, 
mainly in Noord-Brabant Province (11). A campaign of 
voluntary vaccination of dairy goats began at the end of 
2008 in the area of the 2007 human case cluster and was 
followed by mandatory vaccination of all dairy goat and 
dairy sheep on farms with >50 animals in a larger area 
in 2009. This vaccination zone included Noord-Brabant 
Province and parts of adjacent provinces because the 
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supply of vaccine was not suffi cient for all small ruminant 
farms in the Netherlands and because most human cases 
had occurred in that area (Figure 1) (13).
Additional control measures implemented in the fall 
of 2009 were a bulk milk test every 2 weeks to detect C. 
burnetii–infected herds and to monitor C. burnetii–negative 
herds, movement and breeding bans for dairy goats or 
sheep, and culling of all pregnant dairy goats or sheep on 
infected farms. Health authorities considered a farm to 
be infected when 2 consecutive bulk milk samples were 
positive by PCR, as tested by 2 laboratories, including the 
national reference laboratory (17). Thus, culling included 
pregnant goats in vaccinated herds and pregnant goats in 
unvaccinated herds located outside the vaccination zone. 
Culling was conducted from the end of December 2009 
through May 2010.
Vaccine
The vaccine used was Coxevac (Ceva Santé Animale, 
Libourne, France). This vaccine was not registered in the 
Netherlands at the time of the study, but authorities had 
issued a temporary exemption. The vaccine is a phase 
I vaccine containing inactivated C. burnetii strain Nine 
Mile (18). It was recommended that uninfected animals be 
vaccinated twice over a 1-month interval before pregnancy. 
Although effi cacy in dairy goats was not shown, the 
expected effects in vaccinated animals were reduced 
infection, abortion, and bacterial shedding if animals were 
infected after vaccination (19–21).
Study Design
For various reasons related to regulations of the national 
culling operation, unvaccinated dairy goats from 5 farms, 
vaccinated dairy goats from 7 farms, and unvaccinated 
dairy sheep from 1 farm were included in this study. 
Farms were not randomly selected but were selected on 
the basis of convenience of culling date, vaccination status, 
and agreement of farmers to participate in the study. We 
sampled 100 animals per farm, 50 pregnant and lactating 
animals (old animals), and 50 nulliparous animals (young 
animals). With this sample size, we expected to be able to 
detect a 20% difference in C. burnetii prevalence between 
vaccinated and unvaccinated animals and between old and 
young animals. We tested 3 types of samples: 1) uterine 
fl uid, to detect animals with a high risk for shedding around 
parturition; 2) vaginal mucus, to be consistent with test 
results of other studies (19–21); and 3) milk, because herds 
were monitored on the basis of results of bulk milk tests.
On the day before culling, animals were selected and 
marked on the farm by the study team; authorities identifi ed 
pregnancies by using sonography. We selected pregnant 
animals that were closest to giving birth because it was 
expected that these animals had the highest number of C. 
burnetii in birth fl uids, which would facilitate detection of 
infection (4). After animals were humanely killed on farms, 
marked animals were transported in a separate container 
to a rendering plant (Rendac BV, Son, the Netherlands), 
where they were unloaded onto a concrete fl oor and 
prepared for sampling.
Sampling
Uterine fl uid was obtained by using a 9-mL monovette 
EDTA blood collection system (Sarstedt, Nümbrecht, 
Germany) and a Bovivet 2.10 mm × 60 mm needle (Terumo 
Europe NV, Leuven, Belgium). Before obtaining uterine 
fl uid, we made an incision in the linea alba cranial from 
the udder, moved part of the uterus to an extraabdominal 
position, and cleaned the uterus with alcohol-soaked cotton 
balls. We also cleaned the vulva with alcohol-soaked cotton 
balls and then obtained a swab sample from the vagina wall 
by using a dry and sterile cotton-tipped Cultiplast swab (LP 
Italiana SPA, Milan, Italy). These 2 samples were obtained 
from all selected animals. Additionally, from old animals 
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Figure 1. Density of 1,133 reported cases of acute Q fever in 
humans per municipality, the Netherlands, January 1–June 10, 
2009. Area outlined in red is where vaccination of dairy goats and 
sheep was mandatory in 2009 (Noord Brabant Province and parts of 
adjacent provinces). Data were obtained from the National Institute 
for Public Health and the Environment, Statistics Netherlands, the 
Food and Consumer Product Safety Authority, and the Ministry of 
Agriculture, Nature and Food Quality. 
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we obtained a milk sample, which was collected into a 30-
mL sterile tube. The teat was cleaned with alcohol-soaked 
cotton balls before sampling, and the fi rst few streams of 
milk were discarded. All samples were frozen at −40°C 
within a few hours after sampling and were sent to the 
laboratory to be analyzed after the end of the culling period.
Diagnostic Test
Quantitative real-time PCR was performed for all 
samples. Milk samples were analyzed at the Animal Health 
Service by using the Taqvet Coxiella burnetii TaqMan 
Quantitative PCR (Laboratoire Service International, 
Lissieu, France). Swabs and uterine samples were analyzed 
by the national reference laboratory by using an in-
house real-time PCR specifi c for the C. burnetii insertion 
sequence 1111a gene (22). Results for the 3 sample types 
were given as positive, negative, or doubtful on the basis 
of cycle threshold (Ct) values, in which a value <36.01 
was considered positive and a value >40 was considered 
negative. A negative result indicated that no specifi c 
signal was detected in a maximum of 40 cycles. Values 
between 36.01 and 40 were reported as doubtful on the 
basis of <100% reproducibility. For additional analysis, we 
considered all samples with Ct <40 as positive.
Statistical Analyses
Vaccine effi cacy was calculated for young and old 
animals separately for all 3 sample types according to the 
following equation: [% (positive test result, unvaccinated) 
– % (positive test result, vaccinated)] / [% (positive test 
result, unvaccinated)] (23). This effi cacy can be interpreted 
as the percentage of positive samples (Ct <40) prevented by 
vaccination in a vaccinated population.
Infl uence of vaccination and parity on test results of 
individual animals was examined by using logistic regression 
(24) for the 3 sample types. We included vaccination status 
and parity group in the model as explanatory variables. 
Herd was included as a random factor to incorporate the 
fact that observations within a herd are dependent in the 
model. For uterine samples and vaginal swabs, we used 
the equation logit (fraction of positive test results) = parity 
(old) + vaccination status stratifi ed by parity (young or old 
vaccinated) + random herd effect stratifi ed by vaccination 
status (vaccinated or unvaccinated herds). For milk 
samples, we used the equation logit (fraction of positive 
test results) = vaccination status (vaccinated) + random 
herd effect stratifi ed by vaccination. Vaccine effect was 
quantifi ed by calculating the odds ratio (OR).
For positive samples only, we tested whether 
vaccination had an effect on the relative amount of 
bacteria present in each sample type, as indicated by the 
Ct value. A Ct value closer to 0 indicates a higher bacterial 
concentration in the sample relative to a Ct value closer 
to 40. We performed survival analysis on samples with 
Ct values for which the Ct value at which a sample result 
becomes positive is considered the event. Hazard ratio 
(HR) indicates the rate at which samples from unvaccinated 
animals become positive compared with samples from 
vaccinated animals (25). No correction for herd level was 
necessary and no correction for parity was possible because 
of the low number of bacterial shedders per group. For each 
of the 3 samples types, we used the equation Ct value (of 
positive samples only) = vaccination status (vaccinated).
Kaplan-Meier curves were plotted to show bacterial 
load in samples from old vaccinated, young vaccinated, old 
unvaccinated, and young unvaccinated animals. Statistical 
analyses were performed by using R software (26). For 
logistic regression, the function glmer() in lme4 in R 
software (27) was used. For survival analysis, the functions 
Surv() and coxph() in Survival in R software (28) were 
used. The model fi t of all models was assessed by using the 
likelihood ratio test.
Results
Background Information for Individual Farms
Information for each farm is shown in Table 1. Three 
farms (B, F, and K) did not have a history of animals 
with Q fever before the end of 2009 when their bulk milk 
PCR results changed from negative to positive during the 
monitoring period, which suggested a recent infection. 
Abortion caused by Q fever had been diagnosed in 2008 on 
sheep farm X. On all other farms, >1 bulk milk ELISA or 
PCR results were positive for C. burnetii in 2008 or 2009. 
Animals in vaccinated herds were supposedly vaccinated 
twice in 2009, with the exception of farm M, where the fi rst 
vaccination was given after abortions had occurred.
Effect of Vaccination on Bacterial Shedding
Crude test results are summarized in Table 2. The 
percentage of C. burnetii–positive animals on each farm is 
shown in Figure 2. For vaccinated animals, 0.43% of uterine 
samples, 30% of vaginal swabs, and 4% of milk samples 
were positive (Ct <36.01). For unvaccinated animals, 26% 
of uterine samples, 76% of vaginal swabs, and 33% of milk 
samples were positive. Prevalences within vaccinated herds 
and unvaccinated herds varied substantially (Table 2).
Vaccine effi cacy for uterine sample results was 98% 
for young animals and 90% for old animals. Vaginal 
sample vaccine effi cacy was much lower (57% and 28%) 
for young and old animals, respectively. Vaccine effi cacy 
for milk sample test results was 72% (Table 3). All logistic 
regression model fi ts and survival model fi ts were better 
than those of null models according to likelihood ratio tests.
For vaccinated animals, uterine samples from young 
animals were 0.5% as likely to be positive for C. burnetii 
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Table 1. Characteristics of goat and sheep farms sampled for Coxiella burnetii, the Netherlands, January–April 2010*
Farm No. animals culled No. live animals Vaccination period
Bulk milk sample PCR result 
and date of change, 2010†
Unvaccinated goats
A 550 178 NA +
B 102 530 NA Mar
F 53 938 NA Mar
K 121 649 NA Feb
L 324 367 NA +
Unvaccinated sheep
X 128 378 NA Jan
Vaccinated goats
H 365 673 2009 Aug–Dec Jan
M 719 3,557 2009 Dec–2010 Jan +
P 625 1,750 2009 Sep–Dec +
Q 685 281 2009 Aug–Oct +
R 3,595 0 2009 Sep–Oct +
S 180 358 2009 Oct +
T 1,081 83 2009 Apr–Sep +
*Data from Animal Health Service and the Food and Consumer Product Safety Authority. Animals were vaccinated with Coxevac (Ceva Santé Animale, 
Libourne, France). No. live animals is the number of nonpregnant animals remaining after culling. NA, not applicable; +, positive.
†Shown are farms that had a positive PCR result at the start of the culling period (+) and those for which a PCR result changed from negative to positive 
during the culling period (date).
Table 2. Quantitative PCR results and prevalence for samples positive for Coxiella burnetii for 957 animals in 13 small ruminant herds, th
January–April 2010* 
Farm Group 
Uterine fluid Vaginal mucus Milk
No. Pos D % (95% CI) No. Pos D % (95% CI) No. Pos D % (95% CI) 
Unvaccinated goats 
 A Young 46 0 0 0 (0–6) 0 0 0 NA 0 0 0 NA
Old 47 0 2 0 (0–6) 0 0 0 NA 52 8 2 15 (6–25) 
 B Young 74 35 16 47 (36–59) 76 75 0 99 (96–100) 0 0 0 NA
Old 26 10 2 39 (20–57) 26 26 0 100 26 17 8 65 (47–84) 
 F Young 49 35 4 71 (59–84) 53 52 0 98 (95–100) 0 0 0 NA
Old 0 0 0 NA 0 0 0 NA 0 0 0 NA
 K Young 26 17 5 65 (47–84) 32 32 0 100 0 0 0 NA
Old 28 12 3 43 (25–61) 39 39 0 100 34 33 0 97 (91–100) 
 L Young 37 0 0 0 (0–8) 37 2 9 5 (0–13) 0 0 0 NA
Old 58 0 0 0 (0–5) 58 1 3 2 (0–5) 51 2 3 4 (0–9) 
Unvaccinated sheep 
 X Young 17 5 2 29 (8–51) 17 17 0 100 0 0 0 NA
Old 79 11 13 14 (6–22) 82 76 1 93 (87–98) 79 19 18 24 (15–34) 
Vaccinated goats 
 H Young 48 1 0 2 (0–6) 49 1 5 2 (0–6) 0 0 0 NA
Old 50 0 0 0 (0–6) 50 6 11 12 (3–21) 37 0 0 0 (0–8) 
 M Young 50 0 1 0 (0–6) 49 46 2 94 (87–100) 0 0 0 NA
Old 47 1 3 2 (0–6) 48 47 0 98 (94–100) 47 5 12 11 (2–20) 
 P Young 0 0 0 NA 0 0 0 NA 0 0 0 NA
Old 0 0 0 NA 30 12 9 40 (23–58) 30 1 0 3 (0–10) 
 Q Young 49 0 0 0 (0–6) 50 2 8 4 (0–9) 0 0 0 NA
Old 49 0 1 0 (0–6) 50 2 12 4 (0–9) 50 0 2 0 (0–6) 
 R Young 0 0 0 NA 0 0 0 NA  0 0 0 NA
Old 10 0 0 0 (0–26) 0 0 0 NA  10 0 0 0 (0–26) 
 S Young 46 0 0 0 (0–6) 50 4 6 8 (0–16) 0 0 0 NA
Old 25 0 0 0 (0–11) 28 2 5 7 (0–17) 28 1 5 4 (0–10) 
 T Young 49 0 0 0 (0–6) 0 0 0 NA 0 0 0 NA
Old 47 0 0 0 (0–6) 0 0 0 NA 46 3 3 7 (0–14) 
*No., no. tested; pos, no. with positive result; D, no. with doubtful result; %, prevalence; CI, confidence interval; young, nulliparous; NA, not applicable; 
old, pregnant and lactating.  
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(OR 0.005, 95% CI 0.0002–0.1200), and uterine samples 
from old animals were 3.2% as likely to be positive 
(OR 0.032, 95% CI 0.002–0.580) than samples from 
unvaccinated young animals. For unvaccinated animals, 
old animals were 44% as likely to be positive than young 
animals (OR 0.44, 95% CI 0.25–0.78) (Table 4). Results 
from the vaginal swabs were comparable; vaccinated 
young animals were 1.5% as likely to be positive for C. 
burnetii than unvaccinated young animals (OR 0.015, 95% 
CI 0.0006–0.3500). Milk from vaccinated old animals was 
4% as likely to be positive for C. burnetii than milk from 
unvaccinated old animals (OR 0.04, 95% CI 0.003–0.380) 
(Table 5).
Effect of Vaccination on Ct Value
In uterine fl uid, vaccinated animals had an HR that 
was half that of unvaccinated animals (HR 0.49, 95% CI 
0.34–0.70), which indicated that unvaccinated C. burnetii–
positive animals had higher relative amounts of bacteria on 
the basis of Ct value. This effect was similar for vaginal 
mucus (HR 0.34, 95% CI 0.28–0.42) and milk (HR 0.54, 
95% CI 0.39–0.75) (Table 6).
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Figure 2. Kaplan-Meier curves for cycle threshold (Ct) values of all samples (A–C) and for samples with positive and doubtful results for 
Coxiella burnetii (Ct <40) (D–F), the Netherlands, January 1–June 10, 2009. A, D) Uterine fl uid; B, E) vaginal mucus; C, F) milk. Old, 
pregnant and lactating; young, nulliparous.
Table 3. Efficacy of vaccination against Coxiella burnetti for 957 animals in 13 small ruminant herds, the Netherlands, January–April 
2010*
Group
Uterine fluid Vaginal mucus Milk
No. Pos D E, % No. Pos D E, % No. Pos D E, %
Unvaccinated
Young 249 92 27 NA 215 178 9 NA NA NA NA NA
Old 238 33 20 NA 205 142 4 NA 242 79 31 NA
Subtotal 487 125 47 NA 420 320 13 NA 242 79 31 NA
Vaccinated
Young 241 1 1 98 198 53 21 57 NA NA NA NA
Old 228 1 4 90 206 69 37 28 248 10 22 72
Subtotal 470 2 5 NA 404 122 58 NA 248 10 22 NA
Total 957 127 52 NA 824 442 71 NA 490 89 53 NA
*No., no tested; pos, no. with positive result; D, no. doubtful; E, vaccine efficacy; young, nulliparous; NA, not applicable; old, pregnant and lactating. 
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Ct values for uterine fl uid and vaginal mucus were 
lowest for C. burnetii–positive, unvaccinated young 
animals, which suggested that they had the highest relative 
amount of bacteria (Figure 2). Ct values were similar in 
bacteria-positive vaccinated animals, regardless of parity 
group, which indicated lower but similar shedding levels 
in all vaccinated animals. For milk samples, Ct values 
were lower for unvaccinated animals than for vaccinated 
animals.
Discussion
This study showed that vaccination of dairy goats 
against Q fever with Coxevac reduced the percentage of 
animals in which bacteria were detected and bacterial load in 
uterine fl uid, vaginal swabs, and milk. Reduced prevalence 
was most prominent in uterine fl uid and in young animals. 
Because shedding of bacteria may be quantitatively highest 
during parturition, abortion, and subsequent periods, these 
results suggest that vaccination may reduce environmental 
contamination, thereby contributing to reduction of risk for 
human exposure and associated human cases of Q fever.
Our fi ndings are consistent with those of other 
studies. In a clinical trial of cattle, Guatteo et al. (20) 
demonstrated that vaccine was effective in reducing the 
probability of becoming a bacterial shedder when given to 
uninfected animals before pregnancy. Arricau-Bouvery et 
al. (21) showed that vaccination of 17 goats in a clinical 
trial decreased excretion of C. burnetii. Rousset et al. 
(19) conducted a fi eld study of a goat herd infected with 
C. burnetii and found that vaccination did not prevent 
shedding but did reduce bacterial load in vaginal swabs of 
primiparous animals.
Although these studies provided useful data on the 
effect of vaccination, these data were based on a limited 
number of observations. The advantages of our study were 
that it was based on a larger number of fi eld samples (957 
animals from 13 herds) obtained from animals vaccinated 
under fi eld conditions and that it tested uterine fl uid, which 
is likely to be a good proxy for shedding at the time of 
kidding. A disadvantage of our study was its observational 
nature, in which vaccination was not conducted randomly 
at the herd, animal, parity, or infection levels, as would 
have been conducted in a clinical trial.
In unvaccinated herds C. burnetii was detected 
more often in uterine fl uid of young animals than in old 
animals. However, no parity difference was observed for 
vaccinated herds. Rousset et al. (19) observed a reduced 
bacterial load in vaginal swabs in primiparous goats only. 
We also observed that the bacterial load was most reduced 
in young vaccinated animals. However, vaccinated young 
and old animals had similar bacterial loads in uterine fl uid 
and vaginal mucus (Figure 2). Our results suggest that 
vaccination is more protective in nulliparous animals than 
in parous animals. Further investigations are required to 
determine whether the association between vaccination 
and bacterial shedding depends on vaccination before a 
fi rst or subsequent pregnancy or on vaccination before 
or after natural exposure, and to elucidate underlying 
mechanisms.
As reported by Guatteo et al. (20), the time of 
vaccination before or during breeding may affect its 
effectiveness. In our study, whether all animals had been 
vaccinated before breeding was not known. On 1 farm, 
all animals were vaccinated after breeding, and most 
vaccinated animals with a positive test result for C. burnetii 
came from this farm. When we excluded this farm from 
the analyses, we observed a stronger effect of vaccination, 
which indicated that the effect of vaccination could have 
been underestimated.
However, the effi cacy of vaccination may also have 
been overestimated. With exception of the dairy sheep 
farm, all unvaccinated herds with a high prevalence of C. 
burnetii–positive uterine samples had no known history of 
Q fever until milk PCR results became positive during the 
culling period. This result suggested a recent introduction 
of the infectious agent. In other unvaccinated herds that 
had only a few positive uterine samples, C. burnetii was 
384 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 3, March 2011
Table 4. Multivariate logistic regression of prevalence of Coxiella burnetii in culled animals from 13 small ruminant herds, the 
Netherlands, January–April 2010* 
Group 
Uterine fluid Vaginal mucus 
OR (95% CI) p value OR (95% CI) p value 
Unvaccinated
 Young 1 NA 1 NA
 Old 0.44 (0.25–0.78) <0.05 0.22 (0.08–0.64) <0.05
Vaccinated
 Young 0.005 (0.0002–0.12) <0.05 0.015 (0.0006–0.35) <0.05
 Old 0.03 (0.002–0.58) <0.05 0.13 (0.006–3.01) 0.2
*A random herd effect was included. OR, odds ratio; CI, confidence interval; young, nulliparous; NA, not applicable; old, pregnant and lactating. 
Table 5. Univariate logistic regression of prevalence of Coxiella 
burnetii in milk samples from culled animals in 13 small ruminant 
herds, the Netherlands, January–April 2010*
Group OR (95% CI) p value
Old, unvaccinated 1 NA
Old, vaccinated 0.04 (0.003–0.38) <0.05
*A random herd effect was included. OR, odds ratio; CI, confidence 
interval; old, pregnant and lactating; NA, not applicable.
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circulating before the culling period. All vaccinated herds 
appeared to have histories of C. burnetii infection. This 
factor makes it diffi cult to conclude whether absence of 
positive uterine samples in vaccinated herds was caused by 
vaccination or was a combined effect of vaccination and an 
immune response after natural infection.
Another study limitation is that the stage of pregnancy 
can affect the amount of C. burnetii; bacterial load in secreta 
may increase sharply during the last stage of pregnancy (4). 
Although we attempted to select animals that were closest 
to giving birth, not all animals sampled were in the same 
stage of pregnancy, and the average duration of pregnancy 
may have differed from farm to farm. Because data about 
gestation stage were lacking, we did not include this factor 
in our analyses.
Goats and sheep in the Netherlands were vaccinated 
to reduce the number of human cases of Q fever. However, 
other countries use a different strategy. In Australia, 
persons at risk are vaccinated against Q fever (29). In 
France, cattle are vaccinated to prevent economic losses 
caused by abortions (30). No substantial numbers of human 
cases of Q fever have been reported in these countries (31). 
The effect of vaccination in the Netherlands on reduction 
of human exposure could not be quantifi ed. However, the 
low number (≈350) of human cases in 2010 compared 
with those in 2009 (32) suggests a benefi cial effect of 
intervention measures. The relationship between bacterial 
shedding, environmental contamination, and human cases 
needs further investigation.
Our results showed that in uterine fl uid, vaginal mucus, 
and milk, C. burnetii prevalence and load were reduced in 
vaccinated animals in the Netherlands. These effects were 
most pronounced in young primiparous animals. We can 
reasonably assume that vaccination under fi eld conditions 
contributed to reduction of shedding of C. burnetii by dairy 
goats and dairy sheep, which in turn may contribute to 
reduction of the risk for human exposure.
Acknowledgments
We thank the farmers for participating in the study; Herman 
Scholten, Gerrit Koop, Evelien Suij, Christian Scherpenzeel, 
Matthijs Schouten, Ellen Meijer, Aurélie Courcoul, Kelly Still, 
Ruurd Jorritsma, and Ellen van ‘t Veer-Luiten for helping with 
sampling; and Klaas Steijn, Pieter Derks, Herman Jonker, Peter 
Vos, Arie van Nes, Lammert Moll, Edwin Vries, Frans Groenen, 
Steven Danneel, Jan van den Broek, Hans Vernooij, Arnout 
de Bruin, and Jan Slingenbergh for providing suggestions and 
assistance.
Dr Hogerwerf is a veterinarian and disease ecologist at 
Utrecht University. Her research interests are the epidemiology 
and ecology of emerging zoonoses, including Q fever.
References
  1.  Arricau-Bouvery N, Rodolakis A. Is Q fever an emerging or re-
emerging zoonosis? Vet Res. 2005;36:327–49. DOI: 10.1051/
vetres:2005010
  2.  Angelakis E, Raoult D. Q fever. Vet Microbiol. 2010;140:297–309. 
DOI: 10.1016/j.vetmic.2009.07.016
  3.  Norlander L. Q fever epidemiology and pathogenesis. Microbes In-
fect. 2000;2:417–24. DOI: 10.1016/S1286-4579(00)00325-7
  4.  Sánchez J, Souriau A, Buendía AJ, Arricau-Bouvery N, Martínez 
CM, Salinas J, et al. Experimental Coxiella burnetii infection in 
pregnant goats: a histopathological and immunohistochemical study. 
J Comp Pathol. 2006;135:108–15. DOI: 10.1016/j.jcpa.2006.06.003
  5.  Marrie TJ, Durant H, Williams JC, Mintz E, Waag DM. Exposure to 
parturient cats: a risk factor for acquisition of Q fever in maritime 
Canada. J Infect Dis. 1988;158:101–8.
  6.  Tselentis Y, Gikas A, Kofteridis D, Kyriakakis E, Lydataki N, Bouros 
D, et al. Q-fever in the Greek Island of Crete; epidemiologic, clinical 
and therapeutic data from 98 cases. Clin Infect Dis. 1995;20:1311–6.
  7.  Armengaud A, Kessalis N, Desenclos JC, Maillot E, Brousse P, 
Brouqui P, et al. Urban outbreak of Q fever, Briancon, France, 
March to June 1996. Euro Surveill. 1997;2:12–3.
  8.  Lyytikäinen O, Ziese T, Schwartländer B, Matzdorff P, Kuhnhen C, 
Jäger C, et al. An outbreak of sheep-associated Q fever in a rural 
community in Germany. Eur J Epidemiol. 1998;14:193–9. DOI: 
10.1023/A:1007452503863
  9.  ProMED-mail. Q fever-Netherlands (02): (North Brabant). ProMED. 
2009 May 8 [cited 2010 Oct 1]. http://www.promedmail.org, archive 
no. 20090508.1721.
10.  Wouda W, Dercksen D. Abortion and stillbirth among dairy goats 
as a consequence of Coxiella burnetii [in Dutch]. Tijdschr Dierge-
neeskd. 2007;132:908–11.
11.  van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vel-
lema P, Wijkmans C, et al. Q fever in the Netherlands: an update 
on the epidemiology and control measures. Euro Surveill. 2010;15: 
pii:19520. 
12.  van den Brom R, Vellema P. Q fever outbreaks in small rumi-
nants and people in the Netherlands. Small Ruminant Research. 
2009;86:74–9. DOI: 10.1016/j.smallrumres.2009.09.022
13.  Schimmer B, Dijkstra F, Vellema P, Schneeberger PM, Hackert V, ter 
Schegget R, et al. Sustained intensive transmission of Q fever in the 
south of the Netherlands, 2009. Euro Surveill. 2009;14:pii:19210. 
14.  Van Steenbergen JE, Morry G, Groot CAR, Ruikes FGH, Marcelis 
JH, Speelman P. An outbreak of Q fever in The Netherlands—possi-
ble link to goats [in Dutch]. Ned Tijdschr Geneeskd. 2007;151:1998–
2003.
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 3, March 2011 385
Table 6. Univariate survival analysis of PCR Ct values for Coxiella burnetii in positive and doubtful samples from culled animals in 13 
small ruminant herds, the Netherlands, January–April 2010*
Group
Uterine fluid Vaginal mucus Milk
HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Unvaccinated 1 NA 1 NA 1 NA
Vaccinated 0.49 (0.39–0.70) <0.05 0.34 (0.28–0.42) <0.05 0.54 (0.39–0.75) <0.05
*Ct, cycle threshold; HR, hazard ratio; CI, confidence interval; NA, not applicable.
RESEARCH
15.  Klaassen CH, Nabuurs-Franssen M, Tilburg JJ, Hamans MA, Hor-
revorts AM, Multigenotype Q fever outbreak, the Netherlands. 
Emerg Infect Dis. 2009;15:613–4. DOI: 10.3201/eid1504.081612
16.  Schimmer B, ter Schegget R, Wegdam M, Zuchner L, de Bruin A, 
Schneeberger PM, et al. The use of a geographic information system 
to identify a dairy goat farm as the most likely source of an urban 
Q-fever outbreak. BMC Infect Dis. 2010;10:69. DOI: 10.1186/1471-
2334-10-69
17.  Ministry of Agriculture. Nature and food quality (MinLNV). Q fe-
ver [cited 2010 Jul 23]. http://www.minlnv.nl/portal/page?_page-
id=116,1640387&_dad=portal&_schema=PORTAL&p_document_
id=111059&p_node_id=2133602&p_mode=BROWSE
18.  Committee for Medicinal Products for Veterinary Use. Sum-
mary of opinion Coxevac. London: European Medicines Agency; 
2010 [cited 2010 Oct 1]. http://www.ema.europa.eu/docs/en_GB/
document_library/Summary_of_opinion_-_Initial_authorisation/
veterinary/000155/WC500094743.pdf
19.  Rousset E, Durand B, Champion JL, Prigent M, Dufour P, Forfait 
C, et al. Effi ciency of a phase 1 vaccine for the reduction of vaginal 
Coxiella burnetii shedding in a clinically affected goat herd. Clin 
Microbiol Infect. 2009;15(Suppl 2):188–9 . DOI: 10.1111/j.1469-
0691.2008.02220.x
20.  Guatteo R, Seegers H, Joly A, Beaudeau F. Prevention of Coxiella 
burnetii shedding in infected dairy herds using a phase I C. bur-
netii inactivated vaccine. Vaccine. 2008;26:4320–8. DOI: 10.1016/j.
vaccine.2008.06.023
21.  Arricau-Bouvery N, Souriau A, Bodier C, Dufour P, Rousset E, Ro-
dolakis A. Effect of vaccination with phase I and phase II Coxiella 
burnetii vaccines in pregnant goats. Vaccine. 2005;23:4392–402. 
DOI: 10.1016/j.vaccine.2005.04.010
22.  Klee SR, Tyczka J, Ellerbrok H, Franz T, Linke S, Baljer G, et al. 
Highly sensitive real-time PCR for specifi c detection and quan-
tifi cation of Coxiella burnetii. BMC Microbiol. 2006;6:2. DOI: 
10.1186/1471-2180-6-2
23.  Dohoo I, Martin W, Stryhn H. Measures of effect. In: Veterinary 
epidemiologic research. Charlottetown (Prince Edward Island, Can-
ada): VER Inc.; 2009. p. 141.
24.  Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New 
York: John Wiley and Sons; 2000.
25.  Eisenberg SWF, Nielen M, Santema W, Houwers DJ, Heederik D, 
Koets AP. Detection of spatial and temporal spread of Mycobacte-
rium avium subsp. paratuberculosis in the environment of a cattle 
farm through bio-aerosols. Vet Microbiol. 2010;143:284–92. DOI: 
10.1016/j.vetmic.2009.11.033
26.  R Development Core Team. R: a language and environment for sta-
tistical computing. Vienna: R Foundation for Statistical Computing, 
2009 [cited 2010 Oct 1]. http://www.R-project.org
27.  Bates D, Maechler M. lme4: linear mixed-effects models using S4 
classes. R package version 0.999375–33. 2010 [cited 2010 Oct 1]. 
http://CRAN.R-project.org/package=lme4
28.  Therneau T, Lumley T. Survival: survival analysis, including penal-
ized likelihood. R package version 2.35–7; 2009 [cited 2010 Oct 1]. 
http://CRAN.R-project.org/package=survival
29.  Gidding HF, Wallace C, Lawrence GL, McIntyre PB. Australia’s 
national Q fever vaccination program. Vaccine. 2009;27:2037–41. 
DOI: 10.1016/j.vaccine.2009.02.007
30.  Courcoul A, Vergu E, Denis JB, Beaudeau F. Spread of Q fever 
within dairy cattle herds: key parameters inferred using a Bayes-
ian approach. Proc Biol Sci. 2010;277:2857–65. DOI: 10.1098/
rspb.2010.0575
31.  EFSA Panel on Animal Health and Welfare (AHAW). Scien-
tifi c opinion on Q fever. European Food Safety Authority Journal. 
2010; 8:1595 [cited 2010 Jul 23]. http://www.efsa.europa.eu DOI: 
10.2903/j.efsa.2010.1595
32.  National Institute for Public Health and the Environment (RIVM). 
Q fever [in Dutch]. 2010 [cited 2010 Oct 1]. http://www.rivm.nl/cib/
themas/Q-koorts/q-koorts-professionals.jsp
Address for correspondence: Lenny Hogerwerf, Department of Farm 
Animal Health, Faculty of Veterinary Medicine, Utrecht University, 
Yalelaan 7, 3584 CL Utrecht, the Netherlands; email: l.hogerwerf@uu.nl
386 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 3, March 2011
